Gerard J. Criner
Temple University
675 Papers
2K Citations
Gerard J. Criner is an academic researcher from Temple University. The author has contributed to research in topics: Medicine & COPD. The author has an hindex of 73, co-authored 541 publications. Previous affiliations of Gerard J. Criner include University of North Carolina at Chapel Hill & Queen Elizabeth Hospital Birmingham.
Chat about Author
Papers
Incidence of venous thromboembolism in coronavirus disease 2019: An experience from a single large academic center.
Parth Rali,Oisin A. O'Corragain,Lawrence Oresanya,Daohai Yu,Omar Sheriff,Robert Weiss,C.N. Myers,Parag Desai,Nadia Ali,Anthony Stack,Michael Bromberg,Andrea L. Lubitz,J. Panaro,Riyaz Bashir,Vladimir Lakhter,Roberto Caricchio,Rohit Gupta,Chandra Dass,Kumaran Maruti,Xiaoning Lu,A. Koneti Rao,Gary Cohen,Gerard J. Criner,Eric T. Choi,Aaron Mishkin,Abbas Abba,Abhijit S. Pathak,Abhinav Rastogi,Adam Diamond,Aditi Satti,Adria Simon,Ahmed Soliman,Alan Braveman,A.J. Mamary,A. Pandya,Amy Goldberg,Amy Kambo,A.J. Gangemi,Anjali Vaidya,Ann Davison,Anuj Basil,Charles T. Bakhos,Bill Cornwell,Brianna Sanguily,Brittany Corso,Carla Grabianowski,Carly Sedlock,Charles Bakhos,Chenna Kesava Reddy Mandapati,Cherie P. Erkmen,Chethan Gangireddy,Chih-ru Lin,Christopher T. Burks,Claire Raab,Deborah Crabbe,Crystal Chen,Daniel Edmundowicz,Daniel Sacher,Daniel Salerno,Daniele Simon,David Ambrose,David Ciccolella,Debra Gillman,Dolores Fehrle,Dominic Morano,Donnalynn Bassler,Edmund Cronin,Eduardo Dominguez,Ekam Randhawa,Ekamjeet Randhawa,Eman Hamad,Eneida Male,Erin R Narewski,Francis Cordova,Frederic Jaffe,Frederich Kueppers,Fusun Dikengil,J. Galli,Jamie Garfield,Gayle Jones,Gennaro Calendo,Gerard J. Criner,Gilbert E. D'Alonzo,Ginny Marmolejos,Matthew Gordon,Gregory Millio,Fernandez Gustavo,Hannah Simborio,Harwood Scott,Heidi Shore-Brown,Hernan Alvarado,Ho-Man Yeung,I. Yousef,Ifeoma Oriaku,Iris Jung-won Lee,Isaac Whitman,James D.J. Brown,Jamie L. Garfield,Janpreet Mokha,Jason Gallagher,Jeffrey Stewart,Jenna Murray,Jessica Tang,Jeyssa Gonzalez,Jichuan Wu,Jiji Thomas,Jim Murrett,Joanna Beros,John M. Travaline,Jolly Varghese,Jordan Senchak,Joseph Lambert,J.A. Ramzy,Joshua Cooper,Jun Song,J.M. Chowdhury,Kaitlin Kennedy,Karim B. Ahmed,Karim Loukmane,Karthik Shenoy,Kathleen Brennan,Keith Johnson,Kevin Carney,Kraftin Schreyer,Kristin Criner,Maruti Kumaran,Lauren Miller,Laurie Jameson,Laurie Johnson,Laurie Kilpatrick,Lii-Yoong Criner,Lily Zhang,Lindsay K. McGann,Llera A. Samuels,Marc Diamon,Margaret Kerper,Maria Elena Vega Sanchez,Mariola Marcinkienwicz,Maritza Pedlar,Mark Aksoy,Mark Weir,Marla R. Wolfson,Marla Wolfson,R. Marron,Martin G. Keane,M. Zantah,Mathew Zheng,Matthew Delfiner,Maulin Patel,Megan Healy,Melinda Darnell,Melissa Navaro,Meredith A. Brisco-Bacik,Michael Gannon,Michael J. Jacobs,Mira Mandal,Nanzhou Gou,Nathaniel Marchetti,Nathaniel Xander,Navjot Kaur,Neil Nadpara,Nicole Desai,N. Mills,Norihisa Shigemura,Ohoud Rehbini,Oneida Arosarena,Osheen Abramian,Paige Stanley,P. Mulhall,Pravin Patil,Priju Varghe,Puja Dubal,Puja Patel,Rachael Blair,Rajagopalan Rengan,Rami Alashram,Randol Hooper,Rebecca A. Armbruster,Regina Sheriden,Rogers Thomas,Rohit Soans,Roman Petrov,Roman Prosniak,Romulo Fajardo,Ruchi Bhutani,Ryan Townsend,Sabrina Islam,S. Pettigrew,Samantha Wallace,Sameep Sehgal,Samuel Krachman,Santosh Dhungana,Sarah Hoang,Sean Duffy,Seema Rani,Shapiro William,Sheila Weaver,Shelu Benny,Sheril George,Shuang Sun,Shubhra Srivastava-Malhotra,Stephanie Brictson,Stephanie Spivack,Stephanie Tittaferrante,Stephanie Yerkes,Stephen Priest,Steve Codella,Steven G. Kelsen,Steven Houser,S. Verga,Sudhir Bolla,Sudhir Kotnala,Sunil Karhadkar,Sylvia Johnson,Tahseen Shariff,Tammy Jacobs,Thomas Hooper,Tom Rogers,Tony S. Reed,Tse-Shuen Ku,Uma Sajjan,Victor Kim,Whitney Cabey,Wissam Chatila,Wuyan Li,Zach Dorey-Stein,Z. Dorey-Stein,Zachary D. Repanshek +227 more
TL;DR: This study represents one of the earliest reported from the United States on the incidence rate of VTE in patients with COVID-19 and patients with a high clinical suspicion of acute VTE with the identified risk factors should be considered for early VTE testing.
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial.
Fernando J. Martinez,Eric Yow,Kevin R. Flaherty,Laurie D. Snyder,Michael T. Durheim,Michael T. Durheim,Stephen R. Wisniewski,Frank C. Sciurba,Ganesh Raghu,Maria M. Brooks,Dong Yun Kim,Daniel F. Dilling,Gerard J. Criner,Hyun Kuk Kim,Elizabeth A. Belloli,Anoop M. Nambiar,Mary Beth Scholand,Kevin J. Anstrom,Imre Noth +18 more
TL;DR: In this paper, the effect of co-trimoxazole and doxycycline on clinical outcomes in idiopathic pulmonary fibrosis patients was evaluated in a randomized clinical trial.
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia.
Luca Richeldi,Mary Beth Scholand,David A. Lynch,Thomas V. Colby,Jeffrey L. Myers,Steve D. Groshong,Jonathan H. Chung,Sadia Benzaquen,Steven D. Nathan,J Russell Davis,Shelley L. Schmidt,L Hagmeyer,David A. Sonetti,Jürgen Hetzel,Gerard J. Criner,Amy Case,Murali Ramaswamy,Karel Calero,Umair Gauhar,Nina Patel,Lisa Lancaster,Yoonha Choi,Daniel G. Pankratz,P. Sean Walsh,Lori Lofaro,Jing Huang,Sangeeta Bhorade,Giulia C. Kennedy,Fernando J. Martinez,Ganesh Raghu +29 more
TL;DR: Recognition of a UIP pattern by the Envisia Genomic Classifier combined with HRCT and clinical factors in a multidisciplinary discussion may assist clinicians in making an ILD (especially IPF) diagnosis without the need for SLB.
Clinical Trial of Losartan for Pulmonary Emphysema: Pulmonary Trials Cooperative LEEP Trial.
Robert A. Wise,Janet T. Holbrook,Robert H. Brown,Gerard J. Criner,Mark T. Dransfield,Jiaxian He,Robert J. Henderson,David A. Kaminsky,Robert J. Kaner,Stephen C. Lazarus,Barry J. Make,Meredith C. McCormack,Enid Neptune,Loretta G. Que +13 more
TL;DR: In this article , the authors evaluated the efficacy of losartan, an angiotensin receptor blocker (ARB), to reduce emphysema progression in patients with chronic obstructive pulmonary disease.
Optimal Treatment of Chronic Obstructive Pulmonary Disease: The Search for the Magic Combination of Inhaled Bronchodilators and Corticosteroids
TL;DR: On the basis of several studies, experts recommend regular use of long-acting 2-agonists or anticholinergic bronchodilators in moderate to severe COPD to improve FEV1 and quality of life and the prevention and management of exacerbations is targeted.